Human SLPI Quantikine ELISA Kit



Product Details

Reactivity HuSpecies Glossary
Applications ELISA

Order Details

Human SLPI Quantikine ELISA Kit Summary

The Quantikine Human SLPI Immunoassay is a 4.5 hour solid phase ELISA designed to measure SLPI in cell culture supernates, serum, plasma, and urine. It contains E. coli-expressed recombinant human SLPI and antibodies raised against the recombinant factor. The kit has been shown to accurately quantitate recombinant human SLPI. Results obtained using natural human SLPI showed linear c...urves that were parallel to the curves obtained using the recombinant kit standards. These results indicate that this kit can be used to determine relative mass values for natural human SLPI.
Show More
Natural and recombinant human SLPI
Assay Type
Solid Phase Sandwich ELISA
See PDF Datasheet for details
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details


Application Notes
No significant interference observed with available related molecules.
Read Publications using DPI00.

Packaging, Storage & Formulations

Store the unopened product at 2 - 8 °C. Do not use past expiration date.


This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human SLPI Quantikine ELISA Kit

  • ALK1
  • ALPProtease inhibitor WAP4
  • antileukoproteinase
  • BLPISeminal proteinase inhibitor
  • HUSI
  • HUSI-I
  • Mucus proteinase inhibitor
  • secretory leukocyte peptidase inhibitor
  • secretory leukocyte protease inhibitor (antileukoproteinase)
  • Secretory leukocyte protease inhibitor
  • SLPI
  • WAP four-disulfide core domain protein 4
  • WAP4HUSI-1


Secretory leukocyte protease inhibitor (SLPI) is found in various secretory fluids including parotid secretions, bronchial, nasal, cervical mucous, and seminal fluid. SLPI is a potent inhibitor of many proteolytic enzymes including the neutrophil proteases, elastase, cathepsin G, chymotrypsin, and trypsin.

Customers Who Viewed This Item Also Viewed...

Species: Hu, Rt
Applications: CyTOF-ready, ICC, IHC, ICFlow
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu, Mu, Rt
Applications: BA
Species: Hu
Applications: IHC, WB
Species: Hu, Mu, Ye
Applications: ELISA, ICC/IF, IHC, IHC-P, IP, S-ELISA, WB
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ICC, IHC, ICFlow, Simple Western, WB
Species: Mu
Applications: ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, IHC, Neut, WB
Species: Hu
Applications: IHC, IHC-P, WB
Species: Mu
Applications: ELISA
Species: Hu, Mu, Rt
Applications: ICC, KO, Simple Western, WB
Species: Hu
Applications: BA
Species: Hu, Mu, Rt
Applications: BA
Species: Hu
Applications: ELISA, AP, PA, WB
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P
Species: Hu
Applications: ELISA
Species: Ca, Hu, Mu, Po, Pm, Rt(-)
Applications: Dual ISH-IHC, ICC/IF, IHC, IHC-Fr, IHC-P, IP, KO, PLA, WB
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to

Publications for SLPI (DPI00)(34)

We have publications tested in 1 confirmed species: Human.

Filter By Application
All Applications
Filter By Species
All Species
Showing Publications 1 - 10 of 34. Show All 34 Publications.
Publications using DPI00 Applications Species
Y Miyazaki, T Goto, X Li, K Nakayama, K Okasho, M Takeda, K Mizuno, H Kimura, M Uegaki, T Sumiyoshi, Y Teramoto, S Akamatsu, T Kobayashi, O Ogawa, T Inoue Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy Cancer Medicine, 2022-08-13;12(3):3328-3342. 2022-08-13 [PMID: 36812122] (Human) Human
KT Sawicki, DR Nannini, SJ Bielinski, NB Larson, DM Lloyd-Jone, B Psaty, KD Taylor, SJ Shah, LJ Rasmussen-, JT Wilkins, EM McNally, RB Patel Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis Scientific Reports, 2023-01-12;13(1):604. 2023-01-12 [PMID: 36635319] (Human) Human
DL Frey, C Bridson, S Dittrich, SY Graeber, M Stahl, S Wege, F Herth, O Sommerburg, C Schultz, A Dalpke, MA Mall, S Boutin Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis Frontiers in Microbiology, 2022-05-13;13(0):885822. 2022-05-13 [PMID: 35633718] (Human) Human
O Sibila, L Perea, N Albacar, J Moisés, T Cruz, N Mendoza, B Solarat, G Lledó, G Espinosa, JA Barberà, JR Badia, A Agustí, J Sellarés, R Faner Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge Respiratory Research, 2022-02-21;23(1):37. 2022-02-21 [PMID: 35189887] (Human) Human
BL Dickey, B Sirak, L Martin-Gom, RR Reich, M Abrahamsen, K Isaacs-Sor, CH Chung, AR Giuliano Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome PLoS ONE, 2021-07-02;16(7):e0254161. 2021-07-02 [PMID: 34214131] (Human) Human
T Samejima, T Nagamatsu, N Akiba, T Fujii, S Sayama, K Kawana, A Taguchi, K Kumasawa, T Iriyama, Y Osuga, T Fujii Secretory leukocyte protease inhibitor and progranulin as possible regulators of cervical remodeling in pregnancy J Reprod Immunol, 2020-11-01;143(0):103241. 2020-11-01 [PMID: 33157500] (Human) Human
A Stanton, C Mowbray, M Lanz, K Brown, P Hilton, A Tyson-Capp, RS Pickard, ASM Ali, J Hall Topical Estrogen Treatment Augments the Vaginal Response to Escherichia coli Flagellin Sci Rep, 2020-05-21;10(1):8473. 2020-05-21 [PMID: 32439855] (Human) Human
HJ Whitwell, J Worthingto, O Blyuss, A Gentry-Mah, A Ryan, R Gunu, J Kalsi, U Menon, I Jacobs, A Zaikin, JF Timms Improved early detection of ovarian cancer using longitudinal multimarker models Br. J. Cancer, 2020-01-15;0(0):. 2020-01-15 [PMID: 31937926] (Human) Human
L Averdunk, C Fitzner, T Levkovich, DE Leaf, M Sobotta, J Vieten, A Ochi, G Moeckel, G Marx, C Stoppe Secretory Leukocyte Protease Inhibitor (SLPI)-A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study J Clin Med, 2019-11-09;8(11):. 2019-11-09 [PMID: 31717603] (Human) Human
K Kongpol, N Nernpermpi, E Prompunt, S Kumphune Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury Biomolecules, 2019-10-31;9(11):. 2019-10-31 [PMID: 31683729] (Human) Human
Show All 34 Publications.

Reviews for SLPI (DPI00) (0)

There are no reviews for SLPI (DPI00). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for SLPI (DPI00) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human SLPI Quantikine ELISA Kit and receive a gift card or discount.


Gene Symbol SLPI